Functional genomics: paving the way for more successful cancer immunotherapy

被引:5
|
作者
Ajina, Reham [1 ]
Zamalin, Danielle [2 ]
Weiner, Louis M. [3 ,4 ,5 ]
机构
[1] Georgetown Univ, Tumor Biol, Washington, DC 20057 USA
[2] Georgetown Univ, Washington, DC 20057 USA
[3] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr LCCC, Washington, DC 20057 USA
[4] Dept Oncol, Washington, DC USA
[5] MedStar Georgetown Canc Inst, Washington, DC USA
关键词
cancer; functional genomics; immunotherapy; checkpoints; immunity; T-CELL-RECEPTOR; CLONAL EXPANSION; PD-L1; EXPRESSION; OPEN-LABEL; TUMOR; IPILIMUMAB; RESISTANCE; MECHANISMS; BLOCKADE; PEMBROLIZUMAB;
D O I
10.1093/bfgp/ely017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Immunotherapies have revolutionized cancer treatment. Immunotherapy is effective for the treatment of a wide range of cancer types and can mediate complete and durable tumor regression. Nonetheless, the field still faces many significant challenges, such as the need for personalized therapeutic strategies and better biomarkers, the difficulty of selecting the right combination therapy, and resistance to currently available immunotherapies. Both cancer and host immunity comprise significantly diverse and complex ecosystems, making immunogenomics an ideal field for functional genomics analysis. In this review, we describe the cancer-immunity cycle, how cancer cells manage to evade immune attack and the current hurdles in the path of cancer immunotherapy. Then, we discuss how functional genomics approaches can pave the way for more successful cancer immunotherapies.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 50 条
  • [31] Is There a Safer and More Successful Way to Climb Kilimanjaro?
    Mackie, Stephanie
    Windsor, Jeremy S.
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2009, 10 (03) : 301 - 302
  • [32] Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a Cure
    Pasquer, Helene
    Tostain, Maelys
    Kaci, Nina
    Roux, Blandine
    Benajiba, Lina
    CANCERS, 2021, 13 (04) : 1 - 23
  • [33] Cholinergic side Effect-Free anticancer drugs: paving the way for safer and more effective cancer treatment
    Ritu, Prakash
    Chandra, Prakash
    Das, Asmita
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
  • [34] Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy
    Bulashevska, Alla
    Nacsa, Zsofia
    Lang, Franziska
    Braun, Markus
    Machyna, Martin
    Diken, Mustafa
    Childs, Liam
    Koenig, Renate
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Immunogenomics: using genomics to personalize cancer immunotherapy
    Siniard, Rance C.
    Harada, Shuko
    VIRCHOWS ARCHIV, 2017, 471 (02) : 209 - 219
  • [36] Immunogenomics: using genomics to personalize cancer immunotherapy
    Rance C. Siniard
    Shuko Harada
    Virchows Archiv, 2017, 471 : 209 - 219
  • [37] Genomics and emerging biomarkers for immunotherapy of colorectal cancer
    Kather, Jakob Nikolas
    Halama, Niels
    Jaeger, Dirk
    SEMINARS IN CANCER BIOLOGY, 2018, 52 : 189 - 197
  • [38] Neuroblastoma: developmental biology, cancer genomics and immunotherapy
    Nai-Kong V. Cheung
    Michael A. Dyer
    Nature Reviews Cancer, 2013, 13 : 397 - 411
  • [39] Neuroblastoma: developmental biology, cancer genomics and immunotherapy
    Cheung, Nai-Kong V.
    Dyer, Michael A.
    NATURE REVIEWS CANCER, 2013, 13 (06) : 397 - 411
  • [40] Functional genomics and cancer vulnerabilities
    Hahn, William C.
    MOLECULAR CANCER RESEARCH, 2014, 12